Filing Details
- Accession Number:
- 0000899243-23-007725
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-03-09 16:00:15
- Reporting Period:
- 2023-02-20
- Accepted Time:
- 2023-03-09 16:00:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1492674 | T2 Biosystems Inc. | TTOO | Surgical & Medical Instruments & Apparatus (3841) | 204827488 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1665000 | Terrence Michael Gibbs | 101 Hartwell Avenue Lexington MA 02421 | General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-02-20 | 4,000 | $0.00 | 7,333 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-02-22 | 2,145 | $0.65 | 5,188 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2023-02-24 | 2,914 | $0.00 | 8,102 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-02-28 | 1,585 | $0.59 | 6,517 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Disposition | 2023-02-20 | 4,000 | $0.00 | 4,000 | $0.00 |
| Common Stock | Restricted Stock Units | Disposition | 2023-02-24 | 2,914 | $0.00 | 2,914 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 8,000 | No | 4 | M | Direct | ||
| 2,914 | No | 4 | M | Direct |
Footnotes
- Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2018.
- On February 20, 2022 the reporting person was granted 12,000 RSU's that vest in three equal annual installments commencing on February 20, 2023
- On February 24, 2021 the reporting person was granted 8,743 RSU's that vest in three equal annual installments commencing on February 24, 2022.
Billionaire Hedge Funds
